ARTICLE | Company News
Roche sales and marketing update
October 12, 2015 7:00 AM UTC
Roche launched the cobas EGFR Mutation Test v2 in countries that accept CE Mark as a companion diagnostic to select non-small cell lung cancer (NSCLC) patients who are most likely to benefit from tre...